Price T Rowe Associates Inc X Biotech Inc. Call Options Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding XBIT
# of Institutions
51Shares Held
4.87MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.13MShares$3.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.06MShares$3.37 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA452KShares$1.43 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny281KShares$890,8300.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL254KShares$804,4500.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $96.5M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...